Contribution of new coronavirus infection to the development of cardiovascular diseases (systematic review)

In 2020, the National Institute for Health and Care Excellence in the UK   proposed   the concept of post-Covid syndrome. One of the main manifestations of the post-COVID syndrome are cardiovascular diseases (CVD) and dyslipidemia. However, the pathogenetic patterns of CVD development in COVID-19 convalescents remain unclear. The purpose of the systematic review was to analyze research data on the contribution of past new coronavirus infection to the development of dyslipidemia and atherosclerosis-associated diseases (AAD) in the post-COVID period. 106 publications were selected for analysis. After excluding clinical cases, drug studies, literature reviews and publications devoted to the acute period of COVID-19, a total of 19 articles were selected from Russian and international search engines. Analysis of studies has led to the conclusion that COVID-19 infection makes a significant contribution to the development of new AADs and worsening existing. One of the most likely mechanisms for occurrence of this phenomenon seems to be the development of endotheliitis against the background of the course of COVID-19, however, there are not enough works devoted to this problem.